Get started
Author

Maria Bishara

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
2024 · Neil Chanchlani, Simeng Lin, et al. · The Lancet. Gastroenterology & hepatology · 181
PDF
SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF‐1R‐dependent signaling
2014 · Desiree Anthony, Jonathan L. McQualter, et al. · The FASEB Journal · 59
Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study
2024 · Alexander Thomas Elford, Maria Bishara, et al. · Frontline Gastroenterology · 49
PDF
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease
2020 · Abhinav Vasudevan, Nina Parthasarathy, et al. · Alimentary Pharmacology & Therapeutics · 32
Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease
2023 · Neil Chanchlani, Simeng Lin, et al. · Crohn s & Colitis 360 · 14
PDF
Clinical Utility and Cost‐Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine‐Induced Myelosuppression: A Genotype‐First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource
2025 · Christopher Roberts, Jaime Peters, et al. · Alimentary Pharmacology & Therapeutics · 12
PDF
Performance of hospital administrative data for detection of sepsis in Australia: The sepsis coding and documentation (SECOND) study
2022 · Graeme J Duke, Maria Bishara, et al. · Health Information Management Journal · 12
Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease
2022 · Alex Barnes, Soong-Yuan J. Ooi, et al. · Digestive Diseases and Sciences · 10
PDF
Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn’s Disease
2020 · Danny Con, Nina Parthasarathy, et al. · Journal of Crohn s and Colitis · 10
OC4 Understanding anti-TNF treatment failure in Crohn’s disease: mechanisms and management of loss of response to anti-TNF therapy, three-year data from the PANTS study
2024 · Neil Chanchlani, Simeng Lin, et al. · Frontline Gastroenterology · 3
Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study
2025 · Chandni Radia, Yaa Danso, et al. · Journal of Crohn s and Colitis · 2
Rise in Admissions for Acute Severe Ulcerative Colitis at an Australian Health Service With a Culturally and Linguistically Diverse Population
2026 · Ryan Bartlett, Mustafa Mohamedrashed, et al. · JGH Open · 1
The SILVER Platter for Patients with Inflammatory Bowel Disease (IBD): An IBD Pharmacy Technician-Led Subcutaneous Biologic Home Delivery Service Is Associated with Sustained Improvement in Adherence and Active Health Management
2026 · Andrew Leake, Maria Bishara, et al. · Digestive Diseases and Sciences
PDF
P10 Cost-effectiveness of NUDT15 genotype testing to inform thiopurine treatment in inflammatory bowel disease
2025 · Christopher Roberts, Jaime Peters, et al. · Gut
Cross-sectional evaluation of online direct-to-public calprotectin testing
2024 · Maria Bishara, Rebecca Smith, et al. · Frontline Gastroenterology
P62 Online direct-to-public calprotectin testing in the UK: what is out there in 2023?
2024 · Maria Bishara, Rebecca Smith, et al. · Gut
P68 Real-world effectiveness of upadacitinib in crohn’s disease; a UK multicentre retrospective cohort study
2024 · Alexander Elford, Maria Bishara, et al. · Gut
O2 Beyond the first attempt: a multi-centre UK analysis of second JAK inhibitor use in ulcerative colitis
2024 · Yaa Danso, Chadni Radia, et al. · Gut
P91 Prescribing practices of tofacitinib and preferences amongst high-risk patients in the UK
2024 · Maria Bishara, Michelle Clarke, et al. · Gut
O24 Exploring the potential utility of NUDT15 pharmacogenetic testing in clinical practice: a ‘focused reverse phenotyping’ study within the IBD bioresource
2024 · Christopher Roberts, Aleksejs Sazonovs, et al. · Gut
Mo1789 EXPLORING THE POTENTIAL CLINICAL UTILITY OF NUDT15 PHARMACOGENETIC TESTING IN CLINICAL PRACTICE: A 'FOCUSED REVERSE PHENOTYPING’ COHORT STUDY WITHIN THE UK IBD BIORESOURCE
2024 · Christopher Roberts, Aleksejs Sazonovs, et al. · Gastroenterology
Tu1881 REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN CROHN'S DISEASE; A UK MULTICENTRE RETROSPECTIVE COHORT STUDY
2024 · Alexander T. Elford, Maria Bishara, et al. · Gastroenterology
A report on the Australian Drug Induced Liver Injury Network: AusDILIN
2022 · Beverly Rodrigues, Stephen Bloom, et al. · Journal of Hepatology
Works count: 24
Citation count: 385
H-index: 9
I10-index: 9
Year
Topic
Type